Measuring Blood Proteins in Women With Polycystic Ovary Syndrome
Compares kisspeptin, ghrelin and zonulin levels in women with PCOS and insulin resistance.
Plain-language title generated from the registry record
Registry title: Functional Proteins in Polycystic Ovary Syndrome
Key facts
- Where
- Krakow, PolandSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 18-45 years, with or without polycystic ovary syndrome (PCOS). It measures kisspeptin, ghrelin and zonulin in blood.
- Age
- 18 to 45 years
- Sex
- Women only
- Earlier treatment
- People with treated diabetes or other treated metabolic, autoimmune or autoinflammatory diseases cannot join.
Main reasons for not taking part
- Removal of at least one ovary
- Treated diabetes of any type
- Diagnosed and treated metabolic diseases
- Diagnosed and treated autoimmune diseases
- Diagnosed and treated autoinflammatory diseases
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
Source: NCT06793098, who can take part
Where in Poland
- Jagiellonian UniversityKrakow, PolandContact: Iwona Gawron, Ph.D., M.D.Taking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Jagiellonian University
- Trial code
- NCT06793098
- Record updated
- 18 March 2026
- Original description
The concentration of functional proteins: kisspeptin, ghrelin, zonulin will be measured and compared in women with polycystic ovary syndrome (PCOS) and insulin resistance (IR), in women with PCOS without IR, and in women without PCOS.Read full original descriptionShow less
Assessment of the Concentrations of Functional Proteins as Potential Early Markers of Insulin Resistance in Women With Polycystic Ovary Syndrome
The concentration of functional proteins: kisspeptin, ghrelin, zonulin will be measured and compared in women with polycystic ovary syndrome (PCOS) and insulin resistance (IR), in women with PCOS without IR, and in women without PCOS.
Inclusion: women aged 18-45 years.
Exclusion: treated diabetes of any type; diagnosed and treated metabolic diseases; diagnosed and treated autoimmune diseases; diagnosed and treated autoinflammatory diseases; removal of at least one ovary.